Article · Journal · 2025

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

The Lancet Microbe

Citations: 29from other works
Field-weighted impact: 18.641.00 is the world average for its field and year
Among its field: Top 1%by citations, against works of its field and year
Authors: 93from 16 institutions

Authors

93 authors across 16 institutions in 6 countries

The other 53 authors

Fraunhofer Institute for Translational Medicine and Pharmacologyfacility · DE
German Center for Infection Researchfacility · DE
Helmholtz Munichfacility · DE
Institut für Infektions- und Tropenmedizinfacility · DE
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)facility · DE
LMU Klinikumhealthcare · DE
Ludwig-Maximilians-Universität Müncheneducation · DE
Radboud University Medical Centerfunder · NL
Radboud University Nijmegeneducation · NL
University College Londoneducation · GB
University Hospital Colognehealthcare · DE
University of California, San Franciscoeducation · US
University of Cologneeducation · DE
Uppsala Universityeducation · SE

A work can sit in several, each with a score